Cancer Treatment News and Research

RSS

European Commission approves Pfizer’s first oncology biosimilar

Pfizer Inc. today announced the European Commission has approved TRAZIMERA, a biosimilar to Herceptin (trastuzumab), for the treatment of human epidermal growth factor overexpressing breast cancer and HER2 overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.

31 Jul 2018

Patients who underwent blood, marrow transplants may be at high risk of premature death

While blood and marrow transplants can save the life of a pediatric cancer patient, research out of the University of Alabama at Birmingham found that those patients may be at an increased risk of premature death even years or decades after the procedure as compared with the general population.

28 Jul 2018

Tübingen University Hospital introduces its new Elekta Unity cancer treatment system

On July 25, the radiation oncology department at Tübingen University Hospital introduced its new Elekta Unity MR-linac, a groundbreaking cancer treatment system that integrates two critical but distinct technologies in a single platform: a state-of-the-art, high field wide bore 1.5 Tesla MR imaging system and a next-generation linear accelerator.

27 Jul 2018

Survey: Blood cancers still take longer time for diagnosis than other types of cancer

A survey of patients treated for cancer on the NHS in England shows that blood cancers are still taking longer to be diagnosed than other types of cancer.

27 Jul 2018

Patients with colon cancers on the right side have worse survival rates than those with left-sided tumors

Patients with colorectal cancer tumors on the right side may have poorer five-year survival rates than those whose tumors are located on the left side.

24 Jul 2018

Promising approach to stem cell therapy for treating Parkinson's disease

A major factor underlying Parkinson's Disease pathology is the loss of dopamine neurons in the substantia nigra, and thus current therapies often aim to restore dopamine signaling. However, these treatments are not curative.

24 Jul 2018

Study: Many patients concerned about financial impact of cancer diagnosis and treatment

As treatment for early stage breast cancer becomes less extensive and more precise, a new concern is surfacing: Cancer takes an enormous toll financially on many people.

23 Jul 2018

'Financial toxicity' of cancer treatment not adequately addressed by doctors, reveals study

In addition to facing new concerns about their health, individuals who are diagnosed with cancer often worry about the financial burdens of treatment.

23 Jul 2018

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

AbbVie, a research-based global biopharmaceutical company, today announced it submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for venetoclax in combination with a hypomethylating agent or in combination with low-dose cytarabine for the treatment of newly diagnosed patients with acute myeloid leukemia who are ineligible for intensive chemotherapy.

20 Jul 2018

Replacing conventional cancer treatment with complementary therapy linked to increased risk of death

People who received complementary therapy for curable cancers were more likely to refuse at least one component of their conventional cancer treatment, and were more likely to die as a result, according to researchers from Yale Cancer Center and the Cancer Outcomes, Public Policy and Effectiveness Research Center at Yale School of Medicine.

20 Jul 2018

Study uncovers new protein complex that shields broken DNA ends

Scientists have made a major discovery about how cells repair broken strands of DNA that could have huge implications for the treatment of cancer.

19 Jul 2018

Analysis reveals disparities in cancer death rates among minority groups

Analysis of cancer death data from 2008-2014 in New York state revealed high cancer mortality rates among U.S.-born blacks and Puerto Ricans and relatively low cancer mortality rates among Hispanic South Americans and Asians.

19 Jul 2018

Research uncovers new target for therapeutic intervention in breast cancer

Research led by Suresh Alahari, PhD, Professor of Biochemistry and Molecular Biology at LSU Health New Orleans School of Medicine, has shown for the first time that a tiny piece of RNA deregulates energy metabolism, an emerging hallmark of cancer. The finding identifies a new target for therapeutic intervention in breast cancer.

18 Jul 2018

Cancer Treatment News and Research

European Commission approves Pfizer’s first oncology biosimilar

Patients who underwent blood, marrow transplants may be at high risk of premature death

Tübingen University Hospital introduces its new Elekta Unity cancer treatment system

Survey: Blood cancers still take longer time for diagnosis than other types of cancer

Patients with colon cancers on the right side have worse survival rates than those with left-sided tumors

Promising approach to stem cell therapy for treating Parkinson's disease

Study: Many patients concerned about financial impact of cancer diagnosis and treatment

'Financial toxicity' of cancer treatment not adequately addressed by doctors, reveals study

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

Replacing conventional cancer treatment with complementary therapy linked to increased risk of death

Study uncovers new protein complex that shields broken DNA ends

Analysis reveals disparities in cancer death rates among minority groups

Research uncovers new target for therapeutic intervention in breast cancer

New molecule shows great promise for future treatment of many cancers

Staggering prices slow insurers’ coverage of CAR-T cancer therapy

Researchers develop near-infrared fluorophores-based PDT to cure cancer with less side effects

3D modeling of drug resistance could lead to more effective cancer treatment

Calcium electrotransfer could be used to target cancer cells, study finds

Podcast: KHN’s ‘What the Health?’ ACA under fire. Again.

Researchers develop new model for predicting cancer-associated venous thrombosis

Industry Focus eBook - Cell biology (5th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News